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During the last decade many data show that the endothelial cells 
help to co-control the tone of the underlying vascular smooth muscle 
by releasing vasoactive factors. The first demonstration that the 
presence of endothelium can augment, rather than depress, noradre-
naline contractions of isolated blood vessels has been shown with 
arachidonic acid(3). The augmentation was not observed in prepara-
tions in which the endothelium had been removed mechanically. De-
pression of selective and nonselective adrenergic agonist by 
spontaneously released endothelium-derived relaxing factor(s) is 
confirmed in several groups of investigators(2, 5, 6). It is already ac-
cepted that in physiological circumstances the release of relaxing 
factors (nitric oxide, PG I2 and endothelium-derived hyperpolarizing 
factor) appears to predominate(8). 
The main purpose of the present work is to compare the in-
fluence of urea in physiological concentration on noradrenaline con-
traction on both - endothelium-denuded and endothelium-containing 
vascular preparations in a parallel study. 
Thoracic aortas were taken from male Wistar rats weighing 300-
330 g body mass, killed by blow on the head exsanguined. Up to four 
rings 3 mm long were obtained from each animal used:one was in-
tact for a control series; second was denuded by wooden stick - both 
for simultaneous recording; third was denuded and fourth - intact -
for a light microscopic investigation. The rings were suspended 
under isometric regimen (Ugo Basile - Italy pressure transducer) in 
organ baths, filled with 10 ml Krebs-Henseleit solution, aerated with 
95% 02-5% CO2 gas mixture and allowed to equilibrate for 90 min. 
At the end of this period cumulative concentration-response curves 
to noradrenaline 10*9 - 10"3 mol/l (expressed as final molar concen-
trations in chambers) were obtained. Increases in tension are ex-
pressed as percentage of maximal effect of adequate control before 
and after 15 min exposure time of urea 5 mmol/l, without washing 
out.4Statistical evaluation of data(Mean ± S.E.M.) was done by Stu-
dent's t-test for paired observations. 
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It is clear that when urea acts on denuded ring the noradrenaline 
contractions are more augmented (fig. 1) than in endothelium-con-
taining ring(fig.2). The enhancement of adrenergic contractions are 
above EC50 in both cases. It is to be underlined that the maximal ef-
fect of noradrenaline is only significantly higher in denuded rings in 
comprasion with intact ones. As related to urea effect in endothelium-
conteining rings we assume a calcium entry pathway through volt-
age gated calcium channels(1,9) together with a noncompetitive 
increase of alpha-adrenoceptor sensit ivity(9) . However, the 
presence of EDRF(s) counteracts this urea influence in physiological 
conditions. Therefore in denuded rings it is logic to wait a more ex-
pressed augmentation of noradrenaline contractions, because the 
homeostasis is distroyed and new pathophysiological conditions 
exist (2,3,5,6,8). Recently it has been shown that "endothelial cells 
lack a fully functional urea cycle but can convert L-citruline to arginin 
- a prerequisite for the release of EDRF"(4). In this aspect we agree 
that "the reality of the physiological modulation of vascular tone is 
one of interacting and countervailing influences"(7). Ongoing work 
with other adrenergic agonists and urea in pathological concentra-
tions will contribute for a further elucidation of the problem studied. 
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